Azenta, Inc.
Financials
Valuation Metrics
Azenta, Inc.'s Market Cap is $1.38B. At end of 2025 it was $1.53B. Ranked #2328 of 3,111 in US market (top 75%), #928 of 1,445 on NASDAQ (top 64%), #144 of 206 in Health Care Equipment & Services (top 70%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.38B | US#2,328/3,111 Sec#144/206 |
| Revenue | $597M | US#2,265/3,111 Sec#141/206 |
| Net Income | $-178M | US—/3,111 Sec—/206 |
| Total Assets | $1.90B | US#2,099/3,111 Sec#107/206 |
| Net Assets | $1.55B | US#1,451/3,111 Sec#75/206 |
| Employees | 3,000 | US#998/3,111 Sec#82/206 |
| Value | ||
| P/B | 0.89x | US#238/3,111 Sec#13/206 |
| P/S | 2.31x | US#1,365/3,111 Sec#100/206 |
| FCF Yield | 2.08% | US#1,915/3,111 Sec#120/206 |
| Profitability | ||
| ROE | -11.46% | US#2,433/3,111 Sec#136/206 |
| ROA | -9.36% | US#2,642/3,111 Sec#154/206 |
| Op. Margin | -2.62% | US#2,513/3,111 Sec#137/206 |
| Revenue Growth | 0.96% | US#2,157/3,111 Sec#162/206 |
| Financial Health | ||
| Debt Ratio | 22.46% | US#245/3,111 Sec#26/206 |
| Total Debt | $56M | US#2,550/3,111 Sec#149/206 |
| FCF | $29M | US#2,086/3,111 Sec#127/206 |
| Cash | $234M | US#1,611/3,111 Sec#93/206 |
| Current Ratio | 2.83x | US#871/3,111 Sec#91/206 |
| Dividend | ||
| Div. Yield | 0.00% | US—/3,111 Sec—/206 |
| Div. Growth | -75.01% | US—/3,111 Sec—/206 |
| Payout Ratio | 0.00% | US—/3,111 Sec—/206 |
| Performance | ||
| 1Y Return | -7.48% | US#2,415/3,111 Sec#158/206 |
| 1M Return | 15.79% | US#668/3,111 Sec#66/206 |
| From 52W High | -28.30% | US#2,212/3,111 Sec#152/206 |
| 1Y MDD | -60.94% | US#2,745/3,111 Sec#177/206 |
| Trading | ||
| Volume | 987,195 shares | US#2,222/3,111 Sec#158/206 |
| Trading Value | $29M | US#2,249/3,111 Sec#150/206 |
| Per Share | ||
| EPS | $0.58 | US#1,799/3,111 Sec#94/206 |
| BPS | $37.26 | US#651/3,111 Sec#44/206 |
Company Info
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.